{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:38:10Z","timestamp":1790789890101,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Genomics"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>T cell acute lymphoblastic leukemia (T-ALL) defines a group of hematological malignancies with heterogeneous aggressiveness and highly variable outcome, making therapeutic decisions a challenging task. We tried to discover new predictive model for T-ALL before treatment by using a specific pipeline designed to discover aberrantly active gene.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The expression of 18 genes was significantly associated with shorter survival, including ACTRT2, GOT1L1, SPATA45, TOPAZ1 and ZPBP (5-GEC), which were used as a basis to design a prognostic classifier for T-ALL patients. The molecular characterization of the 5-GEC positive T-ALL unveiled specific characteristics inherent to the most aggressive T leukemic cells, including a drastic shut-down of genes located on the mitochondrial genome and an upregulation of histone genes, the latter characterizing high risk forms in adult patients. These cases fail to respond to the induction treatment, since 5-GEC either predicted positive minimal residual disease (MRD) or a short-term relapse in MRD negative patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Overall, our investigations led to the discovery of a homogenous group of leukemic cells with profound alterations of their biology. It also resulted in an accurate predictive tool that could significantly improve the management of T-ALL patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12864-022-08688-1","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T19:02:37Z","timestamp":1656097357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Ectopic expression of a combination of 5 genes detects high risk forms of T-cell acute lymphoblastic leukemia"],"prefix":"10.1186","volume":"23","author":[{"given":"Li-Jun","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Bo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Bourova-Flin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Chuffart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Na","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Qing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ping","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Yi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadi","family":"Khochbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rousseaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Qing","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"8688_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1182\/blood-2016-07-692608","volume":"129","author":"DI Marks","year":"2017","unstructured":"Marks DI, Rowntree C. Management of adults with T-cell lymphoblastic leukemia. Blood. 2017;129:1134\u201342.","journal-title":"Blood"},{"key":"8688_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/jamaoncol.2018.1915","volume":"4","author":"E Jabbour","year":"2018","unstructured":"Jabbour E, Pui CH, Kantarjian H. Progress and Innovations in the Management of Adult Acute Lymphoblastic Leukemia. JAMA Oncol. 2018;4:1413\u201320.","journal-title":"JAMA Oncol"},{"key":"8688_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1182\/blood-2017-10-812933","volume":"131","author":"D O'Connor","year":"2018","unstructured":"O\u2019Connor D. Refining genetic stratification in T-ALL. Blood. 2018;131:271\u20132.","journal-title":"Blood"},{"key":"8688_CR4","doi-asserted-by":"crossref","unstructured":"Berry DA, Zhou S, Higley H, Mukundan L, Fu S, Reaman GH, et al. Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis. JAMA Oncol. 2017;3:e170580.","DOI":"10.1001\/jamaoncol.2017.0580"},{"key":"8688_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1200\/JCO.2017.76.0504","volume":"36","author":"SP Hunger","year":"2018","unstructured":"Hunger SP. Integrated Risk Stratification Using Minimal Residual Disease and Sentinel Genetic Alterations in Pediatric Acute Lymphoblastic Leukemia. J Clin Oncol. 2018;36:4\u20136.","journal-title":"J Clin Oncol"},{"key":"8688_CR6","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1182\/bloodadvances.2017009845","volume":"1","author":"M Br\u00fcggemann","year":"2017","unstructured":"Br\u00fcggemann M, Kotrova M. Minimal residual disease in adult ALL: technical aspects and implications for correct clinical interpretation. Blood Adv. 2017;1:2456\u201366.","journal-title":"Blood Adv"},{"key":"8688_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1717125115","volume":"115","author":"B Chen","year":"2018","unstructured":"Chen B, Jiang L, Zhong ML, Li JF, Li BS, Peng LJ, et al. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2018;115:373\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8688_CR8","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson M, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211\u20138.","journal-title":"Nat Genet"},{"key":"8688_CR9","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","volume":"67","author":"A Malyukova","year":"2007","unstructured":"Malyukova A, Dohda T, von der Lehr N, Akhoondi S, Corcoran M, Heyman M, et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res. 2007;67:5611\u20136.","journal-title":"Cancer Res"},{"key":"8688_CR10","first-page":"47","volume":"360","author":"S Gonzalez-Garcia","year":"2012","unstructured":"Gonzalez-Garcia S, Garcia-Peydro M, Alcain J, Toribio ML. Notch1 and IL-7 receptor signalling in early T-cell development and leukaemia. Curr Top Microbiol Immunol. 2012;360:47\u201373.","journal-title":"Curr Top Microbiol Immunol"},{"key":"8688_CR11","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","volume":"113","author":"V Asnafi","year":"2009","unstructured":"Asnafi V, Buzyn A, Le Noir S, Baleydier F, Simon A, Beldjord K, et al. NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study. Blood. 2009;113:3918\u201324.","journal-title":"Blood"},{"key":"8688_CR12","doi-asserted-by":"publisher","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","volume":"31","author":"A Trinquand","year":"2013","unstructured":"Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, Lambert J, Beldjord K, Lenglin\u00e9 E, et al. Toward a NOTCH1\/FBXW7\/RAS\/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol. 2013;31:4333\u201342.","journal-title":"J Clin Oncol"},{"key":"8688_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","volume":"94","author":"CD Baldus","year":"2009","unstructured":"Baldus CD, Thibaut J, Goekbuget N, Stroux A, Schlee C, Mossner M, et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica. 2009;94:1383\u201390.","journal-title":"Haematologica"},{"key":"8688_CR14","doi-asserted-by":"publisher","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","volume":"27","author":"MR Mansour","year":"2009","unstructured":"Mansour MR, Sulis ML, Duke V, Foroni L, Jenkinson S, Koo K, et al. Prognostic implications of NOTCH1 and FBXW7 mutations in adults with T-cell acute lymphoblastic leukemia treated on the MRC UKALLXII\/ECOG E2993 protocol. J Clin Oncol. 2009;27:4352\u20136.","journal-title":"J Clin Oncol"},{"key":"8688_CR15","doi-asserted-by":"crossref","unstructured":"Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H et al. Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Sci Transl Med. 2013;5:186ra66.","DOI":"10.1126\/scitranslmed.3005723"},{"key":"8688_CR16","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.4161\/cc.25545","volume":"12","author":"S Rousseaux","year":"2013","unstructured":"Rousseaux S, Wang J, Khochbin S. Cancer hallmarks sustained by ectopic activations of placenta\/male germline genes. Cell Cycle. 2013;12:2331\u20132.","journal-title":"Cell Cycle"},{"key":"8688_CR17","doi-asserted-by":"publisher","first-page":"8840","DOI":"10.1038\/ncomms9840","volume":"6","author":"KE Maxfield","year":"2015","unstructured":"Maxfield KE, Taus PJ, Corcoran K, Wooten J, Macion J, Zhou Y, et al. Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer. Nat Commun. 2015;6:8840.","journal-title":"Nat Commun"},{"key":"8688_CR18","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.1038\/ncomms10499","volume":"7","author":"C Wang","year":"2016","unstructured":"Wang C, Gu Y, Zhang K, Xie K, Zhu M, Dai N, et al. Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types. Nat Commun. 2016;7:10499.","journal-title":"Nat Commun"},{"key":"8688_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcancer.2018.08.006","volume":"53","author":"O Gordeeva","year":"2018","unstructured":"Gordeeva O. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy. Semin Cancer Biol. 2018;53:75\u201389.","journal-title":"Semin Cancer Biol"},{"key":"8688_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/ars.2013.5581","volume":"23","author":"A Le Bescont","year":"2015","unstructured":"Le Bescont A, Vitte AL, Debernardi A, Curtet S, Buchou T, Vayr J, et al. Receptor-Independent Ectopic Activity of Prolactin Predicts Aggressive Lung Tumors and Indicates HDACi-Based Therapeutic Strategies. Antioxid Redox Signal. 2015;23:1\u201314.","journal-title":"Antioxid Redox Signal"},{"key":"8688_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/CCO.0000000000000032","volume":"26","author":"J Wang","year":"2014","unstructured":"Wang J, Rousseaux S, Khochbin S. Sustaining cancer through addictive ectopic gene activation. Curr Opin Oncol. 2014;26:73\u20137.","journal-title":"Curr Opin Oncol"},{"key":"8688_CR22","doi-asserted-by":"publisher","first-page":"16527","DOI":"10.18632\/oncotarget.4113","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, Mi JQ, Debernardi A, Vitte AL, Emadali A, Meyer JA, et al. A six gene expression signature defines aggressive subtypes and predicts outcome in childhood and adult acute lymphoblastic leukemia. Oncotarget. 2015;6:16527\u201342.","journal-title":"Oncotarget"},{"key":"8688_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1002\/emmm.201202034","volume":"5","author":"A Emadali","year":"2013","unstructured":"Emadali A, Rousseaux S, Bruder-Costa J, Rome C, Duley S, Hamaidia S, et al. Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers. EMBO Mol Med. 2013;5:1180\u201395.","journal-title":"EMBO Mol Med"},{"key":"8688_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13072-017-0172-y","volume":"11","author":"S El Kennani","year":"2018","unstructured":"El Kennani S, Adrait A, Permiakova O, Hesse AM, Ialy-Radio C, Ferro M, et al. Systematic quantitative analysis of H2A and H2B variants by targeted proteomics. Epigenetics Chromatin. 2018;11:2.","journal-title":"Epigenetics Chromatin"},{"key":"8688_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00726-014-1847-3","volume":"47","author":"A Tanaka-Hayashi","year":"2015","unstructured":"Tanaka-Hayashi A, Hayashi S, Inoue R, Ito T, Konno K, Yoshida T, et al. Is D-aspartate produced by glutamic-oxaloacetic transaminase-1 like 1 (Got1l1): a putative aspartate racemase? Amino Acids. 2015;47:79\u201386.","journal-title":"Amino Acids"},{"key":"8688_CR26","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ccell.2018.02.011","volume":"33","author":"L Li","year":"2018","unstructured":"Li L, Zeng Q, Bhutkar A, Galvan JA, Karamitopoulou E, Noordermeer D, et al. GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth. Cancer Cell. 2018;33:736\u201351.","journal-title":"Cancer Cell"},{"key":"8688_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nature02519","volume":"429","author":"JB Ma","year":"2004","unstructured":"Ma JB, Ye K, Patel DJ. Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Nature. 2004;429:318\u201322.","journal-title":"Nature"},{"key":"8688_CR28","doi-asserted-by":"crossref","unstructured":"Wang Y, Xu Z, Jiang J, Xu C, Kang J, Xiao L, et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell. 2013;25:69\u201380.","DOI":"10.1016\/j.devcel.2013.03.002"},{"key":"8688_CR29","doi-asserted-by":"publisher","first-page":"13616","DOI":"10.1038\/ncomms13616","volume":"7","author":"K Katsushima","year":"2016","unstructured":"Katsushima K, Natsume A, Ohka F, Shinjo K, Hatanaka A, Ichimura N, et al. Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment. Nat Commun. 2016;7:13616.","journal-title":"Nat Commun"},{"key":"8688_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nature13035","volume":"509","author":"RA Signer","year":"2014","unstructured":"Signer RA, Magee JA, Salic A, Morrison SJ. Haematopoietic stem cells require a highly regulated protein synthesis rate. Nature. 2014;509:49\u201354.","journal-title":"Nature"},{"key":"8688_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature18282","volume":"534","author":"S Blanco","year":"2016","unstructured":"Blanco S, Bandiera R, Popis M, Hussain S, Lombard P, Aleksic J, et al. Stem cell function and stress response are controlled by protein synthesis. Nature. 2016;534:335\u201340.","journal-title":"Nature"},{"key":"8688_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.stem.2015.06.002","volume":"17","author":"X Cai","year":"2015","unstructured":"Cai X, Gao L, Teng L, Ge J, Oo ZM, Kumar AR, et al. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. Cell Stem Cell. 2015;17:165\u201377.","journal-title":"Cell Stem Cell"},{"key":"8688_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1091\/mbc.e10-04-0335","volume":"23","author":"TJ Mitchison","year":"2012","unstructured":"Mitchison TJ. The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell. 2012;23:1\u20136.","journal-title":"Mol Biol Cell"},{"key":"8688_CR34","doi-asserted-by":"publisher","first-page":"4608","DOI":"10.1158\/0008-5472.CAN-11-0412","volume":"71","author":"JD Orth","year":"2011","unstructured":"Orth JD, Kohler RH, Foijer F, Sorger PK, Weissleder R, Mitchison TJ. Analysis of mitosis and antimitotic drug responses in tumors by in vivo microscopy and single-cell pharmacodynamics. Cancer Res. 2011;71:4608\u201316.","journal-title":"Cancer Res"},{"key":"8688_CR35","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","volume":"81","author":"RA Weinberg","year":"1995","unstructured":"Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323\u201330.","journal-title":"Cell"},{"key":"8688_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F","volume":"173","author":"JR Nevins","year":"1997","unstructured":"Nevins JR, Leone G, DeGregori J, Jakoi L. Role of the Rb\/E2F pathway in cell growth control. J Cell Physiol. 1997;173:233\u20136.","journal-title":"J Cell Physiol"},{"key":"8688_CR37","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1101\/gad.813200","volume":"14","author":"JW Harbour","year":"2000","unstructured":"Harbour JW, Dean DC. The Rb\/E2F pathway: expanding roles and emerging paradigms. Genes Dev. 2000;14:2393\u2013409.","journal-title":"Genes Dev"},{"key":"8688_CR38","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1016\/j.celrep.2017.09.007","volume":"20","author":"JS Kwon","year":"2017","unstructured":"Kwon JS, Everetts NJ, Wang X, Wang W, Della Croce K, Xing J, et al. Controlling Depth of Cellular Quiescence by an Rb-E2F Network Switch. Cell Rep. 2017;20:3223\u201335.","journal-title":"Cell Rep"},{"key":"8688_CR39","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1182\/blood-2007-01-068478","volume":"110","author":"C Flotho","year":"2007","unstructured":"Flotho C, Coustan-Smith E, Pei D, Cheng C, Song G, Pui CH, et al. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia. Blood. 2007;110:1271\u20137.","journal-title":"Blood"},{"key":"8688_CR40","doi-asserted-by":"publisher","first-page":"13125","DOI":"10.1038\/ncomms13125","volume":"7","author":"N Vannini","year":"2016","unstructured":"Vannini N, Girotra M, Naveiras O, Nikitin G, Campos V, Giger S, et al. Specification of haematopoietic stem cell fate via modulation of mitochondrial activity. Nat Commun. 2016;7:13125.","journal-title":"Nat Commun"},{"key":"8688_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.stem.2016.04.015","volume":"19","author":"M Khacho","year":"2016","unstructured":"Khacho M, Clark A, Svoboda DS, Azzi J, MacLaurin JG, Meghaizel C, et al. Mitochondrial Dynamics Impacts Stem Cell Identity and Fate Decisions by Regulating a Nuclear Transcriptional Program. Cell Stem Cell. 2016;19:232\u201347.","journal-title":"Cell Stem Cell"},{"key":"8688_CR42","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/leu.2012.23","volume":"26","author":"JQ Mi","year":"2012","unstructured":"Mi JQ, Wang X, Yao Y, Lu HJ, Jiang XX, Zhou JF, et al. Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases. Leukemia. 2012;26:1507\u201316.","journal-title":"Leukemia"},{"key":"8688_CR43","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1038\/leu.2012.26","volume":"26","author":"B Chen","year":"2012","unstructured":"Chen B, Wang YY, Shen Y, Zhang WN, He HY, Zhu YM, et al. Newly diagnosed acute lymphoblastic leukemia in China (I): abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries. Leukemia. 2012;26:1608\u201316.","journal-title":"Leukemia"},{"key":"8688_CR44","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.3324\/haematol.2011.059030","volume":"97","author":"L Zuurbier","year":"2012","unstructured":"Zuurbier L, Petricoin EF 3rd, Vuerhard MJ, Calvert V, Kooi C, Buijs-Gladdines JG, et al. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica. 2012;97:1405\u201313.","journal-title":"Haematologica"},{"key":"8688_CR45","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8688_CR46","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"}],"container-title":["BMC Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-022-08688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12864-022-08688-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12864-022-08688-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T21:04:52Z","timestamp":1656104692000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgenomics.biomedcentral.com\/articles\/10.1186\/s12864-022-08688-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["8688"],"URL":"https:\/\/doi.org\/10.1186\/s12864-022-08688-1","relation":{},"ISSN":["1471-2164"],"issn-type":[{"value":"1471-2164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"28 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent and for patients below age 16 guardians provided informed consent for sample collection and research in accord with the Declaration of Helsinki. All methods were carried out in accordance with Declaration of Helsinki and was approved by the Ethics Committee of Shanghai Jiaotong University School of Medicine affiliated Ruijin Hospital (200807).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors except Z. C., declare that there are no conflicts of interest. Z.C. is an employee of PTM Biolabs.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}